{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T06:25:19Z","timestamp":1776752719343,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","content-domain":{"domain":["gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.ygyno.2013.12.020","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T18:03:57Z","timestamp":1387562637000},"page":"S3-S8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"S1","title":["Pharmacist authority to provide HPV vaccine: Novel partners in cervical cancer prevention"],"prefix":"10.1016","volume":"132","author":[{"given":"Noel T.","family":"Brewer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake K.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah M.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchel C.","family":"Rothholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer S.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2013.12.020_bb0005","author":"Centers for Disease Control, Prevention (CDC)"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer Statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"issue":"20","key":"10.1016\/j.ygyno.2013.12.020_bb0015","first-page":"626","article-title":"FDA licensure of bivalent human papilomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"CDC","year":"2010","journal-title":"MMWR"},{"issue":"50","key":"10.1016\/j.ygyno.2013.12.020_bb0020","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males\u2014Advisory Committee on Immunization Practices (ACIP), 2011","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR"},{"issue":"29","key":"10.1016\/j.ygyno.2013.12.020_bb0030","first-page":"591","article-title":"Human papillomavirus vaccination coverage among adolescent girls, 2007\u20132012, and postlicensure vaccine safety monitoring","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR"},{"issue":"34","key":"10.1016\/j.ygyno.2013.12.020_bb0035","first-page":"685","article-title":"National and state vaccination coverage among adolescents aged 13\u201317 years\u2014United States, 2012","volume":"62","author":"CDC","year":"2013","journal-title":"MMWR"},{"issue":"2\u20133","key":"10.1016\/j.ygyno.2013.12.020_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ypmed.2007.05.013","article-title":"Predictors of HPV vaccine acceptability: a theory-informed, systematic review","volume":"45","author":"Brewer","year":"2007","journal-title":"Prev Med"},{"issue":"8","key":"10.1016\/j.ygyno.2013.12.020_bb0045","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.annepidem.2009.03.011","article-title":"Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus","volume":"19","author":"Dempsey","year":"2009","journal-title":"Ann Epidemiol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.12.020_bb0050","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jadohealth.2008.06.009","article-title":"Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes","volume":"43","author":"Rosenthal","year":"2008","journal-title":"J Adolesc Health"},{"issue":"3","key":"10.1016\/j.ygyno.2013.12.020_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.socscimed.2009.05.024","article-title":"Parents' health beliefs and HPV vaccination of their adolescent daughters","volume":"69","author":"Reiter","year":"2009","journal-title":"Soc Sci Med"},{"issue":"34","key":"10.1016\/j.ygyno.2013.12.020_bb0060","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1016\/j.vaccine.2011.06.020","article-title":"HPV vaccine and adolescent males","volume":"29","author":"Reiter","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ygyno.2013.12.020_bb0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1542\/peds.2009-3500","article-title":"Human papillomavirus vaccination practices: a survey of US physicians 18months after licensure","volume":"126","author":"Daley","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0070","first-page":"1","article-title":"Promising alternative settings for providing HPV vaccine in the U.S.","author":"Shah","year":"2013","journal-title":"Expert Review of Vaccines"},{"issue":"18","key":"10.1016\/j.ygyno.2013.12.020_bb0075","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0264-410X(98)00131-5","article-title":"Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals","volume":"16","author":"Grabenstein","year":"1998","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.020_bb0080","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1331\/JAPhA.2010.09168","article-title":"Vaccination delivery by chain pharmacies in California: Results of a 2007 survey","volume":"50","author":"Pilisuk","year":"2010","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.020_bb0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1086-5802(16)31066-X","article-title":"Implementation of a pharmacy-based immunization program in a supermarket chain","volume":"40","author":"Weitzel","year":"2000","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0090","series-title":"Adapted from a document presented to HHS Secretary Shalala and the National Vaccination Program Office","article-title":"Every month should be immunization month\u2026until everyone is vaccinated","author":"American Pharmaceutical Association","year":"1994"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.020_rf0125","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1331\/154434506776180621","article-title":"Pharmacist involvement with immunizations: a decade of professional advancement","volume":"46","author":"Hogue","year":"2006","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.ygyno.2013.12.020_rf0130","first-page":"308","article-title":"Review","volume":"46","year":"2006","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.020_bb0100","doi-asserted-by":"crossref","DOI":"10.4161\/hv.22614","article-title":"Correlates of comfort with alternative settings for HPV vaccine delivery","volume":"9","author":"McRee","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0105","author":"CDC"},{"issue":"8","key":"10.1016\/j.ygyno.2013.12.020_bb0110","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.vaccine.2003.08.045","article-title":"The role of pharmacists in the delivery of influenza vaccinations","volume":"22","author":"Steyer","year":"2004","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.ygyno.2013.12.020_bb0115","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10461-013-0427-y","article-title":"We can do more than just sell the test: pharmacist perspectives about over-the-counter rapid HIV tests","volume":"17","author":"Meyerson","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0120","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1331\/154434506777069598","article-title":"Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals","volume":"46","author":"Snella","year":"2006","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.ygyno.2013.12.020_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1331\/JAPhA.2010.09199","article-title":"Comparative effectiveness of two pharmacy-based colorectal cancer screening interventions during an annual influenza vaccination campaign","volume":"50","author":"Potter","year":"2010","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.ygyno.2013.12.020_bb0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.18553\/jmcp.2009.15.1.32","article-title":"Evaluation of the first year of a pilot program in community pharmacy: HIV\/AIDS medication therapy management for Medi-Cal beneficiaries","volume":"15","author":"Hirsch","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0135","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1331\/JAPhA.2008.07140","article-title":"The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia","volume":"48","author":"Bunting","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.ygyno.2013.12.020_bb0140","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1331\/JAPhA\/2008.07032","article-title":"Human papillomavirus vaccine and cervical cancer prevention: practice and policy implications for pharmacists","volume":"48","author":"McIntosh","year":"2008","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0145","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/canjclin.57.1.7","article-title":"American Cancer Society guidelines for human papillomavirus (HPV) vaccine use to prevent clinical cancer and its precursors","volume":"57","author":"Saslow","year":"2007","journal-title":"A Cancer J Clin"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0150","series-title":"President's cancer panel annual report 2012\u20132013","article-title":"Accelerating HPV vaccine uptake: urgency for action to prevent cancer","author":"President's Cancer Panel","year":"2013"},{"issue":"1","key":"10.1016\/j.ygyno.2013.12.020_bb0155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1542\/peds.110.1.184","article-title":"The medical home","volume":"110","author":"The American Academy of Pediatrics (AAP)","year":"2002","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.ygyno.2013.12.020_bb0160","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1542\/peds.2006-2681","article-title":"AAP principles concerning retail-based clinics","volume":"118","author":"AAP","year":"2006","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.ygyno.2013.12.020_bb0165","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/1544345054475414","article-title":"North Carolina family practice physicians' perceptions of pharmacists as vaccinators","volume":"45","author":"Welch","year":"2005","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.ygyno.2013.12.020_bb0170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.acap.2011.07.004","article-title":"Pediatricians' attitudes about collaborations with other community vaccinators in the delivery of seasonal influenza vaccine","volume":"12","author":"Kempe","year":"2012","journal-title":"Acad Pediatr"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0175","unstructured":"Personal communication, Beth Rowe-West, May 2012."},{"key":"10.1016\/j.ygyno.2013.12.020_bb0180","author":"American Pharmacists Association"},{"key":"10.1016\/j.ygyno.2013.12.020_bb0185","first-page":"311","article-title":"Promoting the pharmacist's role in public health","volume":"46","author":"Stergachis","year":"2006"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301384X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009082581301384X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,20]],"date-time":"2022-03-20T11:09:07Z","timestamp":1647774547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009082581301384X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":37,"alternative-id":["S009082581301384X"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.020","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacist authority to provide HPV vaccine: Novel partners in cervical cancer prevention","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}